*123I-mIBG was used in 94.8% (73/77) and131I-mIBG used in 5.2% (4/77) of scans, with the same radioisotope used for imaging at both time points. 2 patients were missing scan type and 1 patient reported different scan types at diagnosis and end of induction.
TABLE 2 EFS and OS by optimal CS at diagnosis, end of induction, and relative reduction in CS in tandem transplant recipients (n=80)